Neural Immunity and Human Immunodeficiency Virus-1-Associated Dementia

Blood-Spinal Cord and Brain Barriers in Health and Disease

Volumn , Issue , 2004, Pages 547-559

  Anderson, Eric ^a,b   Ryan, Lisa ^a,b   Xiong, Huangui ^a,b   Swindells, Susan ^b   Zheng, Jialin ^a,b   Gendelman, Howard E ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Chemokines; Cytokines; HIV 1; HIV 1 associated dementia; Neurotoxicity; Viral structural and regulatory proteins

Indexed keywords

EID: 84939873061     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012639011-7/50030-9     Document Type: Chapter

References (163)

1. Adamson D.C., Wildemann B., Sasaki M., Glass J.D., McArthur J.C., Christov V.I., Dawson T.M., Dawson V.L. Immunologic no synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996, 274:1917-1926.
2. Albright A.V., Shieh J.T., Itoh T., Lee B., Pleasure D., O'connor M.J., Doms R.W., Gonzalez-Scarano F. Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the pricipal coreceptor for human immunodeficiency virus type 1 dementia isolates. J. Virol. 1999, 73:205-213.
3. Amirayan-Chevillard N., Tissot-Dupont H., Capo C., Brunet C., Dignat-George F., Obadia Y., Gallais H., Mege J.L. Impact of highly active anti-retroviral therapy (HAART) on cytokine production and monocyte subsets in HIV-infected patients. Clin. Exp. Immunol. 2000, 120:107-112.
4. Ammassari A., Cingolani A., Pezzotti P., De Luca D.A., Murri R., Giancola M.L., Larocca L.M., Antinori A. AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology 2000, 55:1194-1200.
5. Anderson E.R., Boyle J., Persidsky Y., Gendelman H.E., Xiong H. Hippocampal synaptic dysfunction in a murine model of human immunodeficiency virus type I encephalitis. Neuroscience 2003, 118(2):359-369.
6. Anderson E.R., Zink W.E., Boyle J., Rodriguez-Sierra J., Persidsky Y., Gendelman H.E., Xiong H. Linking neuronal physiology and behavior changes during HIV-1 encephalitis in SCID mice. Midwest Student Biomedical Research Forum 2001.
7. Autran B., Carcelain G., Li T.S., Blanc C., Mathez D., Tubiana R., Katlama C., Debre P., Leibowitch J. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997, 277:112-116.
8. Avgeropoulos N., Kelley B., Middaugh L., Arrigo S., Persidsky Y., Gendelman H., Tyor W. SCID mice with HIV-1 encephalitis develop behavioral abnormalities. J. Acquired Immunodeficiency Synd. Hum. Retrovirol. 1998, 18:13-20.
9. Banks W.A. Physiology and pathology of the blood-brain barrier: Implications for microbial pathogenesis, drug delivery and neurodegenerative disorders. J. Neurovirol. 1999, 5:538-555.
10. Banks W.A., Freed E.O., Wolf K.M., Robinson S.M., Franko M., Kumar V.B. Transport of human immunodeficiency virus type 1 pseudoviruses across the blood-brain barrier: Role of envelope proteins and adsorptive endocytosis. J. Virol. 2001, 75:4681-4691.
11. Basso M.R., Bornstein R.A. Neurobehavioural consequences of substance abuse and HIV infection. J. Psychopharmacol. 2000, 14:228-237.
12. Bell J.E., Brettle R.P., Chiswick A., Simmonds P. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS: Effect of neocortical involvement. Brain 1998, 121:2043-2052.
13. Bell M.D., Taub D.D., Perry V.H. Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines. Neuroscience 1996, 74:283-292.
14. Bennett B.A., Rusyniak D.E., Hollingsworth C.K. HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures. Brain Res. 1995, 705:168-176.
15. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA 1995, 92:7162-7166.
16. Brew B.J., Pemberton L., Cunningham P., Law M.G. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J. Infect. Dis. 1997, 175:963-966.
17. Brightman M.W., Ishihara S., Chang L. Penetration of solutes, viruses, and cells across the blood-brain barrier. Curr. Top. Microbiol. Immunol. 1995, 202:63-78.
18. Budka H. Multinucleated giant cells in the brain: A hallmark on the acquired immunodeficiency syndrome (AIDS). Acta Neuropathol. (Berl.) 1986, 69:253-256.
19. Chang L., Ernst T., Leonido-Yee M., Walot I., Singer E. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology 1999, 52:100-108.
20. Chang L., Ernst T., Leonido-Yee M., Witt M., Speck O., Walot I., Miller E.N. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 1999, 53:782-789.
21. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P.D., Wu L., Mackay C.R., LaRosa G., Newman W., Gerard N., Gerard C., Sodroski J. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996, 85:1135-1148.
22. Chong W.K., Sweeney B., Wilkinson I.D., Paley M., Hall-Craggs M.A., Kendall B.E., Shepard J.K., Beecham M., Miller R.F., Weller I.V., et al. Proton spectroscopy of the brain in HIV infection: Correlation with clinical, immunologic, and MR imaging findings. Radiology 1993, 188:119-124.
23. Chow K.U., Mitrou P.S., Geduldig K., Helm E.B., Hoelzer D., Brodt H.R. Changing incidence and survival in patients with aids-related non-hodgkin's lymphomas in the era of highly active antiretroviral therapy (haart). Leukocyte Lymphoma 2001, 41:105-116.
24. Collman R.G., Yi Y., Liu Q.H., Freedman B.D. Chemokine signaling and HIV-1 fusion mediated by macrophage CXCR4: Implications for target cell tropism. J. Leukocyte Biol. 2000, 68:318-323.
25. Conant K., Garzino-Demo A., Nath A., McArthur J.C., Halliday W., Power C., Gallo R.C., Major E.O. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl. Acad. Sci. USA 1998, 95:3117-3121.
26. Cotter R.L., Zheng J., Che M., Niemann D., Liu Y., He J., Thomas E., Gendelman H.E. Regulation of human immunodeficiency virus type 1 infection, β-chemokine production, and CCR5 expression in CD40L-stimulated macrophages: Immune control of viral entry. J. Virol. 2001, 75:4308-4320.
27. Cotter R.L., Burke W.J., Thomas V.S., Potter J.F., Zheng J., Gendelman H.E. Insights into the neurodegenerative process of Alzheimer's disease: A role for mononuclear phagocyte-associated inflammation and neurotoxicity. J. Leukocyte Biol. 1999, 65:416-427.
28. Cotter R.L., Zheng J., Che M., Niemann D., Liu Y., He J., Thomas E., Gendelman H.E. Regulation of human immunodeficiency virus type 1 infection, beta-chemokine production, and CCR5 expression in CD40L-stimulated macrophages: Immune control of viral entry. J. Virol. 2001, 75:4308-4320.
29. Coughlan C.M., McManus C.M., Sharron M., Gao Z., Murphy D., Jaffer S., Choe W., Chen W., Hesselgesser J., Gaylord H., Kalyuzhny A., Lee V.M., Wolf B., Doms R.W., Kolson D.L. Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons. neuroscience 2000, 97:591-600.
30. Davis L.E., Hjelle B.L., Miller V.E., Palmer D.L., Llewellyn A.L., Merlin T.L., Young S.A., Mills R.G., Wachsman W., Wiley C.A. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992, 42:1736-1739.
31. Desbaillets I., Tada M., de Tribolet N., Diserens A.C., Hamou M.F., Van Meir E.G. Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int. J. Cancer. 1994, 58:240-247.
32. Desrosiers R.C., Hansen-Moosa A., Mori K., Bouvier D.P., King N.W., Daniel M.D., Ringler D.J. Macrophage-tropic variants of SIV are associated with specific AIDS-related lesions but are not essential for the development of AIDS. Am. J. Pathol. 1991, 139:29-35.
33. Dhawan S., Weeks B.S., Soderland C., Schnaper H.W., Toro L.A., Asthana S.P., Hewlett I.K., Stetler-Stevenson W.G., Yamada S.S., Yamada K.M., et al. HIV-1 infection alters monocyte interactions with human microvascular endothelial cells. J. Immunol. 1995, 154:422-432.
34. Dickson D.W. Multinucleated giant cells in acquired immunodeficiency syndrome encephalopathy: Origin from endogenous microglia?. Arch. Pathol. Lab. Med. 1986, 110:967-968.
35. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.H., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993, 7:75-83.
36. Diop A.G., Lesort M., Esclaire F., Sindou P., Couratier P., Hugon J. Tetrodotoxin blocks HIV coat protein (gp120) toxicity in primary neuronal cultures. Neurosci. Lett. 1994, 165:187-190.
37. Dore G.J., Correll P.K., Li Y., Kaldor J.M., Cooper D.A., Brew B.J. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 1999, 13:1249-1253.
38. Eddleston M., Mucke L. Molecular profile of reactive astrocytes: Implications for their role in neurologic disease. neuroscience 1993, 54:15-36.
39. Ellis R.J., Hsia K., Spector S.A., Nelson J.A., Heaton R.K., Wallace M.R., Abramson I., Atkinson J.H., Grant I., McCutchan J.A. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome: HIV Neurobehavioral Research Center Group. Ann. Neurol. 1997, 42:679-688.
40. Elovaara I., Iivanainen M., Valle S.L., Suni J., Tervo T., Lahdevirta J. CSF protein and cellular profiles in various stages of HIV infection related to neurological manifestations. J. Neurol. Sci. 1987, 78:331-342.
41. Epstein L.G., Gelbard H.A. HIV-1-induced neuronal injury in the developing brain. J. Leukocyte Biol. 1999, 65:453-457.
42. Fein G., Fletcher D.J., Di Sclafani V. Effect of chronic alcohol abuse on the CNS morbidity of HIV disease. Alcohol. Clin. Exp. Res. 1998, 22:196S-200S.
43. Fiala M., Zhang L., Gan X., Sherry B., Taub D., Graves M.C., Hama S., Way D., Weinand M., Witte M., Lorton D., Kuo Y.M., Roher A.E. Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model. Mol. Med. 1998, 4:480-489.
44. Fong A.M., Robinson L.A., Steeber D.A., Tedder T.F., Yoshie O., Imai T., Patel D.D. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med. 1988, 188:1413-1419.
45. Gabuzda D., Wang J. Chemokine receptors and virus entry in the central nervous system. J. Neurovirol. 1999, 5:643-658.
46. Gartner S. HIV infection and dementia. Science 2000, 287:602-604.
47. Gelbard H., Nottet H., Dzenko K., Jett M., Genis P., White R., Wang L., Choi Y-B., Zhang D., Lipton S., swindells S., Epstein L., Gendelman H. Platelet-activating factor: A candidate human immunodeficiency virus type-1 infection neurotoxin. J. Virol. 1994, 68:4628-4635.
48. Gelbard H.A., Dzenko K., Diloreto D., Cerro C.D., Cerro M.D., Epstein L.G. Neurotoxic effects of tumor necrosis factor in primary human neuronal cultures are mediated by activation of the glutamate AMPA recetor subtypes implications for AIDS neuropathogenesis. Dev. Neurosci. 1993, 15:417-422.
49. Gendelman H., Lipton S., Tardieu M., Bukrinsky M., Nottet H. The neuropathogenesis of HIV-1 infection. J. Leukocyte Biol. 1994, 56:389-398.
50. Gendelman H., Persidsky Y., Ghorpade A., Limoges J., Stins M., Fiala M., Morrisett R. The neuropathogenesis of AIDS dementia complex. AIDS 1997, 11:S35-S45.
51. Gendelman H.E. The neuropathogenesis of HIV-1-dementia. The Neurology of AIDS 1997, 1-10. Chapman and Hall, New York. H.E. Gendelman, S.A. Lipton, L.G. Epstein, S. Swindells (Eds.).
52. Gendelman H.E., Orenstein J.M., Baca L.M., et al. The macrophage in the persistence and pathogenesis of HIV-1 infection. AIDS 1989, 3:475-495.
53. Gendelman H.E., Zheng J., Coulter C.L., Ghorpade A., Che M., Thylin M., Rubocki R., Persidsky Y., Hahn F., Reinhard J., Swindells S. Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J. Infect. Dis. 1998, 178:1000-1007.
54. Genis P., Jett M., Bernton E., Boyle T., Gelbard H., Dzenko K., Keane R., Resnick L., Mizrachi Y., Volsky D., Epstein L., Gendelman H. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: Implications for the neuropathogenesis of HIV disease. J. Exp. Med. 1992, 176:1703-1718.
55. Ghorpade A., Xia M.Q., Hyman B.T., Persidsky Y., Nukuna A., Bock P., Che M., Limoges J., Gendelman H.E., Mackay C.R. Role of the β-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia. J. Virol. 1998, 72:3351-3361.
56. Giulian D. Microglia and the immune pathology of Alzheimer disease. Am. J. Hum. Genet. 1999, 65:13-18.
57. Giulian D., Yu J., Xia L., Tom D., Li J., Lin S.N., Schwarz R., Noonan C. Study of receptor-mediated neurotoxins released by HIV-1 infected mononuclear phagocytes found in human brain. J. Neurosci. 1996, 16:3139-3153.
58. Glass J.D., Fedor H., Wesselingh S.L., McArthur J.C. Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia. Ann. Neurol. 1995, 38:755-762.
59. Hall M., Whaley R., Robertson K., Hamby S., Wilkins J., Hall C. The correlation between neuropsychological and neuroanatomic changes over time in asymptomatic and symptomatic HIV-1-infected individuals. Neurology 1996, 46:1697-1702.
60. He J., Chen Y., Farzan M., Choe H., Ohagen A., Gartner S., Busciglio J., Yang X., Hofmann W., Newman W., Mackay C.R., Sodroski J., Gabuzda D. CCR3 and CCR5 are coreceptors for HIV-1 infection of microglia. Nature 1997, 385:645-649.
61. Henriksen S.J., Prospero-Garcia O., Phillips T.R., Fox H.S., Bloom F.E., Elder J.H. Feline immunodeficiency virus as a model for study of lentivirus infection of the central nervous system. Curr. Top. Microbiol. Immunol. 1995, 202:167-186.
62. Hesselgesser J., Halks-Miller M., DelVecchio V., Peiper S.C., Hoxie J., Kolson D.L., Taub D., Horuk R. CD4-independent association between HIV-1 gp120 and CXCR4: Functional chemokine receptors are expressed in human neurons. Curr. Biol. 1997, 7:112-121.
63. Hesselgesser J., Taub D., Baskar P., Greenberg M., Hoxie J., Kolson D.L., Horuk R. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha mediated by the chemokine receptor CXCR4. Curr. Biol. 1998, 8:595-598.
64. Heyes M.P., Ellis R.J., Ryan L., Childers M.E., Grant I., Wolfson T., Archibald S., Jernigan T.L. Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection. Brain 2001, 124:1033-1042.
65. Heyes M.P., Brew B.B., Martin A., Price R.W., Salazar A., Sidtis J.J., Yergey J.A., Mouradian M.M., Sadler A.E., Keilp J., Rubinow R., Markey S.P. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: Relationship to clinical and neurological status. Ann. Neurol. 1991, 29:202-209.
66. Hurwitz A.A., Berman J.W., Rashbaum W.K., Lyman W.D. Human fetal astrocytes induce the expression of blood-brain barrier specific proteins by autologous endothelial cells. Brain Res. 1993, 625:238-243.
67. Jain K.K. Evaluation of memantine for neuroprotection in dementia. Exp. Opin. Invest. Drugs 2000, 9:1397-1406.
68. Jarvik J.G., Lenkinski R.E., Saykin A.J., Jaans A., Frank I. Proton spectroscopy in asymptomatic HIV-infected adults: Initial results in a prospective cohort study. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1996, 13:247-253.
69. Jiang Z., Piggee C., Heyes M.P., Murphy C., Quearry B., Bauer M., Zheng J., Gendelman H.E., Markey S.P. Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages. J. Neuroimmunol. 2001, 117:97-107.
70. Kaul M., Garden G.A., Lipton S.A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001, 410:988-994.
71. Kaul M., Lipton S.A. Chemokines and activated macrophages in HIV gp 120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA 1999, 96:8212-8216.
72. Kerr S.J., Armati P.J., Guillemin G.J., Brew B.J. Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex. AIDS 1998, 12:355-363.
73. Kornbluth R.S., Kee K., Richman D.D. CD40 ligand (CD154) stimulation of macrophages to produce HIV-1 suppressice B-chemokines. Proc. Natl. Acad. Sci. USA 1998, 95:5205-5210.
74. Krajewski S., James H.J., Ross J., Blumberg B.M., Epstein L.G., Gendelman H.E., Gummuluru S., Dewhurst S., Sharer L.R., Reed J.C., Gelbard H.A. Expression of pro-and anti-apoptosis gene products in brain from paediatric patients with HIV-1 encephalitis. Neuropathol. Appl. Neurobiol. 1997, 23:242-253.
75. Kravcik S., Gallicano K., Roth V., Cassol S., Hawley-Foss N., Badley A., Cameron D.W. Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir. J. Acquir. Immune Defic. Syndr. 1999, 21:371-375.
76. Lavi E., Strizki J.M., Ulrich A.M., Zhang W., Fu L., Wang Q., O'Connor M., Hoxie J.A., Gonzalez-Scarano F. CXCR-4 (fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1) is expressed in the human brain in a variety of cell types, including microglia and neurons. Am. J. Pathol. 1997, 151:1035-1042.
77. Lien E., Aukrust P., Sundan A., Muller F., Froland S.S., Espevik T. Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: Correlation to disease progression and clinical events. Blood 1998, 92:2084-2092.
78. Limoges J., Poluektova L., Ratanasuwan W., Rasmussen J., Zelivyanskaya M., McClernon D.R., Lanier E.R., Gendelman H.E., Persidsky Y. The efficacy of potent anti-retroviral drug combinations tested in a murine model of HIV-1 encephalitis. Virology 2001, 281:21-34.
79. Lipton S.A. Requirement for macrophages in neuronal injury induced by HIV envelope protein gp 120. Neuroreport 1992, 3:913-915.
80. Lipton S.A. Neuronal injury associated with HIV-1 and potential treatment with calcium-channel and NMDA antagonists. Dev. Neurosci. 1994, 16:145-151.
81. Liu Y., Tang X.P., McArthur J.C., Scott J., Gartner S. Analysis of human immunodeficiency virus type 1 gp 160 sequences from a patient with HIV dementia: Evidence for monocyte trafficking into brain. J. Neurovirol. 2000, 6(Suppl. 1):S70-S81.
82. Lopez-Villegas D., Lenkinski R.E., Frank I. Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc. Natl. Acad. Sci. USA 1997, 94:9854-9859.
83. Martin C., Sonnerborg A., Svensson J.O., Stahle L. Indinavir-based treatment of HIV-1 infected patients: Efficacy in the central nervous system. AIDS 1999, 13:1227-1232.
84. Maschke M., Kastrup O., Esser S., Ross B., Hengge U., Hufnagel A. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J. Neurol. Neurosurg. Psychiatry 2000, 69:376-380.
85. Masliah E., Ge N., Achim C.L., DeTeresa R., Wiley C.A. Patterns of neurodegeneration in HIV encephalitis. Neuro-AIDS 1996, 1:161-173.
86. Masliah E., Heaton R.K., Marcotte T.D., Ellis R.J., Wiley C.A., Mallory M., Achim C.L., McCutchan A., Nelson J.A., Atkinson J.H., Grant I. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. Ann. Neurol. 1997, 42:963-972.
87. McArthur J., Grant I. HIV neurocognitive disorders. The Neurology of AIDS 1998, 333-352. Chapman and Hall, New York. R.G. Gonzalez, A. Ruiz, I. Tracey, D. Phil, J. McConnell (Eds.).
88. McConnell J.R., Swindells S., Ong C.S., Gmeiner W.H., Chu W.K., Brown D.K., Gendelman H.E. Prospective utility of cerebral proton magnetic resonance spectroscopy in monitoring HIV infection and its associated neurological impairment. AIDS Res. Hum. Retro 1994, 10:977-982.
89. McGeer E.G., McGeer P.L. The role of the immune system in neurodegenerative disorders. Mov. Disord. 1997, 12:855-858.
90. Mellors J.W., Munoz A., Giorgi J.V., Margolick J.B., Tassoni C.J., Gupta P., Kingsley L.A., Todd J.A., Saah A.J., Detels R., Phair J.P., Rinaldo C.R. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med. 1997, 126:946-954.
91. Meltzer M.S., Gendelman H.E. Mononuclear phagocytes as targets, tissue reservoirs, and immunoregulatory cells in human immunodeficiency virus disease. Curr. Top. Microbiol. Immunol. 1992, 181:239-263.
92. Meyerhoff D.J., MacKay S., Bachman L., Poole N., Dillon W.P., Weiner M.W., Fein G. Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: In vivo 1H magnetic resonance spectroscopic imaging. Neurology 1993, 43:509-515.
93. Michael N.L., Moore J.P. HIV-1 entry inhibitors: Evading the issue. Nature Med 1999, 5:740-742.
94. Mollace V., Nottet H.S., Clayette P., Turco M.C., Muscoli C., Salvemini D., Perno C.F. Oxidative stress and neuroAIDS: Triggers, modulators and novel antioxidants. Trends Neurosci. 2001, 24:411-416.
95. Moore J., Trkola A., Dragic T. Co-receptors for HIV-1 entry. Curr. Opin. Immunol. 1997, 9:551-562.
96. Morris R. Spatial localization does not require the presence of local cues. Learn. Motiv. 1981, 12:239-260.
97. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods. 1984, 11:47-60.
98. Muller W.E., Schroder H.C., Ushijima H., Dapper J., Bormann J. gp 120 of HIV-1 induces apoptosis in rat cortical cell cultures: Prevention by memantine. Eur. J. Pharmacol. 1992, 226:209-214.
99. Nath A., Booze R.M., Hauser K.F., Mactutus C.F., Bell J., Cass W.A., Maragos W., Berger J.R. Interactions of drugs of abuse and HIV dementia. NeuroAids 1999, 2.
100. Navia B.A., Cho E.S., Petito C.K., Price R.W. The AIDS dementia complex II. Neuropathology. Ann. Neurol. 1986, 19:525-535.
101. Navia B.A., Jordan B.D., Price R.W. The AIDS dementia complex. I. Clinical features. Ann. Neurol. 1986, 19:517-524.
102. Norenberg M.D. Astrocyle responses to CNS injury. J. Neuropathol. Exp. Neurol. 1994, 53:213-220.
103. Nottet H.S. Interactions between macrophages and brain microvascular endothelial cells: Role in pathogenesis of HIV-1 infection and blood-brain barrier function. J. Neurovirol. 1999, 5:659-669.
104. Nottet H., Dhawan S. HIV-1 entry into the brain: Mechanisms for the infiltration of HIV-1 infected macrophages across blood-brain barrier. The Neurology of AIDS 1997, Chapman and Hall, New York. H. Gendelman, S. Lipton, L. Epstein, S. Swidells (Eds.).
105. Nottet H.S., Jett M., Flanagan C.R., Zhai Q.H., Persidsky Y., Rizzino A., Bernton E.W., Genis P., Baldwin T., Schwartz J.H., LaBenz C.J., Gendelman H.E. A regulatory role for astrocytes in HIV-1 encephalitis: An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J. Immunol. 1995, 154:3567-3581.
106. Nottet H.S., Persidsky Y., Sasseville V.G., Nukuna A.N., Bock P., Zhai Q.H., Sharer L.R., McComb R.D., Swindells S., Soderland C., Gendelman H.E. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J. Immunol. 1996, 156:1284-1295.
107. Nottet H.S.L.M., Asbeck B.S., Graaf L., Vos M., Visser M.R., Verhoef J. Role for oxygen radicals in self-sustained HIV-1 replication in monocyte-derived macrophages: Enhanced HIV-1 replication by N-acetyl-L-cysteine. J. Leukocyte Biol. 1994, 56:702-707.
108. Persidsky Y. Model systems for studies of leukocyte migration across the blood-brain barrier. J. Neurovirol. 1999, 5:579-590.
109. Persidsky Y., Ghorpade A., Rasmussen J., Limoges J., Liu X.J., Stins M., Fiala M., Way D., Kim K.S., Witte M.H., Weinand M., Carhart L., Gendelman H.E. Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 1999, 155:1599-1611.
110. Persidsky Y., Limoges J., McComb R., Bock P., Baldwin T., Tyor W., Patil A., Nottet H.S., Epstein L., Gelbard H., Flanagan E., Reinhard J., Pirruccello S.J., Gendelman H.E. Human immunodeficiency virus encephalitis in SCID mice. Am. J. Pathol. 1996, 149:1027-1053.
111. Persidsky Y., Limoges J., Rasmussen J., Zheng J., Gearing A., Gendelman H.E. Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis. J. Neuroimmunol. 2001, 114:57-68.
112. Persidsky Y., Rasmussen J., Suryadevara R., Poluektova L., Zelivyanskaya M., Moran T., Miller D., Gendelman H.E. Impairments of blood-brain barrier function in HIV-1-associated dementia. "7th Conference on Retroviruses and Opportunistic Infections" Foundation for Retrovirology and 2000, Human Health, San Francisco.
113. Persidsky Y., Stins M., Way D., et al. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J. Immunol. 1997, 158:499-510.
114. Pierson T., McArthur J., Siliciano R.F. Reservoirs for HIV-1: Mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu. Rev. Immunol. 2000, 18:665-708.
115. Pomara N., Crandall D.T., Choi S.J., Johnson G., Lim K.O. White matter abnormalities in HIV-1 infection: A diffusion tensor imaging study. Psychiat. Res. 2001, 106:15-24.
116. Post M.J., Berger J.R., Duncan R., Quencer R.M., Pall L., Winfield D. Asymptomatic and neurologically symptomatic HIV-seropositive subjects: Results of long-term MR imaging and clinical follow-up. Radiology 1993, 188:727-733.
117. Power C., Kong P.-A., Crawford T.O., Wesselingh S., Glass J.D., McArthur J.C., Trapp B.D. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood-brain barrier. Ann. Neurol. 1993, 34:339-350.
118. Pugh C.R., Johnson J.D., Martin D., Rudy J.W., Maier S.F., Watkins L.R. Human immunodeficiency virus-1 coat protein gp 120 impairs contextual fear conditioning: A potential role in AIDS related learning and memory impairments. Brain Res. 2000, 861:8-15.
119. Pulliam L., Gascon R., Stubblebine M., Mcguire D., McGrath M.S. Unique monocyte subset in patients with AIDS dementia. Lancet 1997, 349:692-695.
120. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16:675-686.
121. Royal W. Neurologic disease in injection drug users: Therapeutic issues. J. Neurovirol. 2000, 6(Suppl. 1):S33-S37.
122. Ryan L., Zheng J., Brester M., Bohac D., Hahn F., Anderson J., Ratanasuwan W., Gendelman H.E., Swindells S. Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type I infection. J. Infect. Dis. 2001, 184(6):699-706.
123. Ryan L.A., Cotter R.L., Zink W.E., Gendelman H.E., Zheng J. Macrophages, chemokines, and neuronal injury in HIV-1-associated dementia. Cell Mol. Biol. (Noisy-le-grand) 2002, 48(2):137-150.
124. Sabri F., De Milito A., Pirskanen R., Elovaara I., Hagberg L., Cinque P., Price R., Chiodi F. Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex. J. Neuroimmunnol. 2001, 114:197-206.
125. Sacktor N., Lyles R.H., Skolasky R., Kleeberger C., Selnes O.A., Miller E.N., Becker J.T., Cohen B., McArthur J.C. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study 1990-1998. Neurology 2001, 56:257-260.
126. Saitoh T., Kang D., Mallory M., DeTeresa R., Masliah E. Glial cells in Alzheimer's disease Preferential effect of APOE risk on scattered microglia. Geronology 1997, 43:109-118.
127. Sala M., Vartanian J.P., Kousignian P., Delfraissy J.F., Taoufik Y., Wain-Hobson S., Gasnault J. Progressive multifocal leukoencephalopathy in human immunodeficiency virus type l-infected patients: Absence of correlation between JC virus neurovirulence and polymorphisms in the transcriptional control region and the major capsid protein loci. J. Gen. Virol. 2001, 82:899-907.
128. Salvan A.M., Vion-Dury J., Confort-Gouny S., Nicoli F., Lamoureux S., Cozzone P.J. Brain proton magnetic resonance spectroscopy in HIV-related encephalopathy: Identification of evolving metabolic patterns in relation to dementia and therapy. AIDS Res. Hum. Retrovir. 1997, 13:1055-1066.
129. Samuelsson A., Brostrom C., van Dijk N., Sonnerborg A., Chiodi F. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection: Correlation with clinical progression. viral load, and loss of humoral immunity. Virology 1997, 238:180-188.
130. Sasseville J.G., Smith M.M., Mackay C.R., Pauley D.R., Mansfield K.G., Ringler D.J., Lackner A.A. Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. Am. J. Pathol. 1996, 149:1459-1467.
131. Schifitto G., Sacktor N., Marder K., McDermott M.P., McArthur J.C., Kieburtz K., Small S., Epstein L.G. Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium. Neurol. 1999, 53:391-396.
132. Schmidtmayerova H., Nottet H.S.L.M., Nuovo G., Raabe T., Flanagan C.R., Dubrovsky L., Gendelman H.E., Cerami A., Bukrinsky M., Sherry B. HIV-1 infection alters chemokine β peptide expression in human monocytes: Implications for recruitment of leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. USA 1996, 93:700-704.
133. Sharer L.R., Cho E.S., Epstein L.G. Multinucleated giant cells and HTLV-III in AIDS encephalopathy. Hum. Pathol. 1985, 16:760.
134. Shor-Posner G. Cognitive function in HIV-1-infected drug users. J. Acquir. Immune Defic. Syndr. 2000, 25(Suppl. 1):S70-S73.
135. Sloand E.M., Maciejewski J.P., Sato T., Bruny J., Kumar P., Kim S., Weichold F.F., Young N.S. The role of interleukin-converting enzyme in Fas-mediated apoptosis in HIV-1 infection. J. Clin Invest. 1998, 101:195-201.
136. Sousa A.E., Chaves A.F., Doroana M., Antunes F., Victorino R.M. Early reduction of the over-expression of CD40L OX40 and Fas on T cells in HIV-1 infection during tripl anti-retroviral therapy: Possible implications for lymphocyte traffic and functional recovery. Clin. Exp. Immunol. 1990, 116:307-315.
137. Sporer B., Koedel U., Goebel F.D., Pfister H.W. Increased levels of soluble Fas receptor and Fas ligand in the cerebrospinal fluid of HIV-infected patients. AIDS Res. Hum., Retrovir. 2000, 16:221-226.
138. Steigerwald E.S., Sarter M., March P., Podell M. Effects of feline immunodeficiency virus on cognition and behavioral function in cats. J. Acquir. Immune Defic. Syndr. Hum. Retrovivol. 1999, 20:411-419.
139. Swindells S., McConnell J.R., McComb R.D., Gendelman H.E. Utility of cerebral proton magnetic resonance spectroscopy in differential diagnosis of HIV-related dementia. J. Neurovirol. 1995, 1:268-274.
140. Talley A.K., Dewhurst S., Perry S.W., Dollard S.C., Gummuluru S., Fine S.M., New D., Epstein L.G., Gendelman H.E., Gelbard H.A. Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: Protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol. Cell Biol. 1995, 15:2359-2366.
141. Tong N., Perry S.W., Zhang Q., James H.J., Guo H., Brooks A., Bal H., Kinnear S.A., Fine S., Epstein L.G., Dairaghi D., Schall T.J., Gendelman H.E., Dewhurst S., Sharer L.R., Gelbard H.A. Neuronal fractalkine expression in HIV-1 encephalitis: Roles for macrophage recruitment and neuroprotection in the central nervous system. J. Immunol. 2000, 164:1333-1339.
142. Tracey I., Carr C.A., Guimaraes A.R., Worth J.L., Navia B.A., Gonzalez R.G. Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: A proton magnetic resonance spectroscopic study. Neurology 1996, 46:783-788. [published erratum appears in Neurology46(6), 1787 (1996)].
143. Tyor W.R., Middaugh L.D. Do alcohol and cocaine abuse alter the course of HIV-associated dementia complex. J. Leukocyte Biol. 1999, 65:475-481.
144. Tyor W.R., Power C., Gendelman H.E., Markham R.B. A model of human immunodeficiency virus encephalitis in scid mice. Proc. Natl. Acad. Sci. USA 1993, 90:8658-8662.
145. Vallat A.-V., Girolami U.D., He J., Mhashikar A., Marasco W., Shi B., Gray F., Bell J., Keohane C., Smith T.W., Gabuzda D. Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. Am. J. Pathol. 1998, 152:167-178.
146. Viswanathan R., Pilman M., Hasaj M. New-onset amnestic syndrome in AIDS patients with past history of alcohol abuse. Psychosomatics 1998, 39:551-553.
147. von Giesen H.J., Hefter H., Jablonowski H., Arendt G. HAART is neuroprophylactic in HIV-1 infection. J. Acquir. Immune Defic. Syndr. 2000, 23:380-385.
148. Westmoreland S.V., Rottman J.B., Williams K.C., Lackner A.A., Sasseville V.G. Chemokine receptor expression on resident and inflammatory cells in the brain of macaques with simian immunodeficiency virus encephalitis. Am. J. Pathol. 1998, 152:659-665.
149. Woodman S.E., Benveniste E.N., Nath A., Berman J.W. Human immunodeficiency virus type 1 TAT protein induces adhesion molecule expression in astrocytes. J. Neurovirol. 1999, 5:678-684.
150. Wu D.T., Woodman S.E., Weiss J.M., McManus C.M., D'Aversa T.G., Hesselgesser J., Major E.O., Nath A., Berman J.W. Mechanisms of leukocyte trafficking into the CNS. J. Neurovirol. 2000, 6(Suppl. 1):S82-S85.
151. Wu V.W., Schwartz J.P. Cell culture models for reactive gliosis New perspectives. J. Neurosci. Res. 1998, 51:675-681.
152. Xiong H., Zeng Y.C., Zheng J., Thylin M., Gendelman H.E. Soluble HIV-1 infected macrophage secretory products mediate blockade of long-term potentiation: A mechanism for cognitive dysfunction in HIV-1-associated dementia. J. Neurovirol. 1999, 5:519-528.
153. Xiong H., Zeng Y.C., Lewis T., Zheng J., Persidsky Y., Gendelman H.E. HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: Relevance for HIV-1-associated dementia. J. Neurovirol. 2000, 6(Suppl. 1):S14-S23.
154. Yi Y., Rana S., Turner J.D., Gaddis N., Collman R.G. CXCR-4 is expressed by primary macrophages and supports CCR-5 independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. J. Virol. 1998, 72:772-777.
155. Zheng J., Gendelman H.E. The HIV-1-associated dementia complex: A metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr. Opin. Neurol. 1997, 10:319-325.
156. Zheng J., Ghorpade A., Niemann D., Cotter R.L., Thylin M.R., Epstein L., Swartz J.M., Shepard R.B., Liu X., Nukuna A., Gendelman H.E. Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: Implications for human immunodeficiency virus type 1-associated dementia. J. Virol. 1999, 73:8256-8267.
157. Zheng J., Lopez A., Erichsen D., Bauer M., Cotter R.L., Ryan L.A., Williams C., Ghorpade A., Morgello S., Gendelman H.E. Macrophage chemotaxis and activation by fractalkine A role for neuronal injury in brain immunity during HIV-1-associated dementia. 8th Conference on Retroviruses and Opportunistic Infections 2001, 44. Foundation for Retrovirology and Human Health, Chicago.
158. Zheng J., Niemann D., Bauer M., Leisman G.B., Cotter R.L., Ryan L.A., Lopez A., Williams C., Ghorpade A., Gendelman H.E. a-chemokines and their receptors in the neuronal signaling: Relevance for HIV-1-associated dementia. 7th Conference on Retroviruses and Opportunistic Infections 2000, Foundation for Retrovirology and Human Health, San Francisco.
159. Zheng J., Thylin M., Ghorpade A., Xiong H., Persidsky Y., Cotter R., Niemann D., Che M., Zeng Y., Gelbard H., Shepard R., Swartz J., Gendelman H. Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J. Neuroimmunol. 1999, 98:185-200.
160. Zhu T., Mo H., Wang N., Nam D.S., Cao Y., Koup R.A., Ho D.D. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993, 261:1179-1181.
161. Zink M.C., Amedee A.M., Mankowski J.L., Craig L., Didier P., Carter D.L., Munoz A., Murphey-Corb M., Clements J.E. Pathogenesis of SIV encephalitis. Am. J. Pathol. 1997, 151:793-803.
162. Zink W., Anderson E., Boyle J., Hock L., Rodriguez-Sierra J., Xiong H., Gendelman H., Persidsky Y. Impaired spatial cognition and synaptic potentiation in a murine model of human immunodeficiency virus type 1 encephalitis. J. Neurosci 2001, 22(6):2096-2105.
163. Zink W.E., Zheng J., Persidsky Y., Poluektova I., Gendelman H.E. The neuropathogenesis of HIV-1 infection. FEMS Immunol. Med. Microbiol. 1999, 26:233-241.